Back
Brady Corp. 10K Form
Buy
64
BRC
Brady Corp.
Last Price:
$77.97
Seasonality Move:
4.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-22 | 10Q | BRC/Brady Corp. Quarterly |
| 2024-02-22 | 10Q | BRC/Brady Corp. Quarterly |
| 2023-11-16 | 10Q | BRC/Brady Corp. Quarterly |
| 2023-09-05 | 10K | BRC/Brady Corp. Annual |
| 2023-05-18 | 10Q | BRC/Brady Corp. Quarterly |
| 2023-02-24 | 10Q | BRC/Brady Corp. Quarterly |
Receive BRC News And Ratings
See the #1 stock for the next 7 days that we like better than BRC
BRC Financial Statistics
Sales & Book Value
| Annual Sales: | $1.5B |
|---|---|
| Cash Flow: | $22.4M |
| Price / Cash Flow: | 23.39 |
| Annual Sales: | $26.37 |
| Price / Book: | 2.95 |
Profitability
| EPS (TTM): | 4.09620 |
|---|---|
| Net Income (TTM): | $196.4M |
| Gross Margin: | $761.4M |
| Return on Equity: | 16.83% |
| Return on Assets: | 11.63% |
Brady Corp. Earnings Forecast
Key Brady Corp. Financial Ratios
-
The Gross Profit Margin over the past 42 years for BRC is 50.30%.
-
The Selling, General & Administrative Expenses for BRC have been equal to 29.35% of Gross Profit Margin.
-
The Research & Development expenses have been 5.28% of Revenue.
-
The Interest Expense is 2.51% of Operating Income.
-
The Net Earning history of BRC is 12.50% of Total Revenues.
-
Per Share Earnings over the last 42 years have been positive in 26 years.
Brady Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Commercial Services & Supplies |
| Sector: | Industrials |
| Current Symbol: | BRC |
| CUSIP: | 104674 |
| Website: | bradyid.com |
Debt
| Debt-to-Equity Ratio: | 0.14 |
|---|---|
| Current Ratio: | 2.07 |
| Quick Ratio: | 1.37 |
Price-to-Earnings
| Trailing P/E Ratio: | 19.81 |
|---|---|
| Forward P/E Ratio: | 14.19 |
BRC Technical Analysis vs Fundamental Analysis
Buy
64
Brady Corp. (BRC)
is a Buy
Is Brady Corp. a Buy or a Sell?
-
Brady Corp. stock is rated a BuyThe current Brady Corp. [BRC] share price is $77.95. The Score for BRC is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.